A detailed history of Jpmorgan Chase & CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,593,181 shares of BMRN stock, worth $171 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,593,181
Previous 2,422,002 7.07%
Holding current value
$171 Million
Previous $212 Million 0.93%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$74.43 - $92.22 $12.7 Million - $15.8 Million
171,179 Added 7.07%
2,593,181 $213 Million
Q1 2024

May 10, 2024

SELL
$83.81 - $99.0 $2.16 Million - $2.55 Million
-25,790 Reduced 1.05%
2,422,002 $212 Million
Q4 2023

Feb 12, 2024

SELL
$76.22 - $98.51 $13 Million - $16.8 Million
-171,040 Reduced 6.53%
2,447,792 $236 Million
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $639,301 - $710,017
7,515 Added 0.29%
2,618,832 $232 Million
Q2 2023

Aug 11, 2023

BUY
$86.68 - $100.3 $4.97 Million - $5.76 Million
57,391 Added 2.25%
2,611,317 $226 Million
Q1 2023

May 18, 2023

BUY
$87.74 - $117.27 $674,106 - $900,985
7,683 Added 0.3%
2,553,926 $248 Million
Q1 2023

May 11, 2023

SELL
$87.74 - $117.27 $1.26 Million - $1.69 Million
-14,401 Reduced 0.56%
2,546,243 $248 Million
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $41 Million - $55 Million
506,252 Added 24.64%
2,560,644 $265 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $36.1 Million - $42.6 Million
439,075 Added 27.18%
2,054,392 $174 Million
Q2 2022

Aug 11, 2022

BUY
$71.48 - $86.85 $1.75 Million - $2.13 Million
24,508 Added 1.54%
1,615,317 $134 Million
Q1 2022

May 11, 2022

BUY
$74.28 - $92.69 $22.1 Million - $27.5 Million
296,868 Added 22.94%
1,590,809 $123 Million
Q4 2021

Feb 10, 2022

SELL
$71.72 - $91.47 $117 Million - $150 Million
-1,635,035 Reduced 55.82%
1,293,941 $114 Million
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $219 Million - $250 Million
2,928,976 New
2,928,976 $226 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.